ArticleFrontiers in endocrinology2024

Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.